NYSEHealth CareHealth Information ServicesSnapshot 2026-07-23
Reading AMWL? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a speculative growth opportunity. AMWL is currently loss-making and faces challenges in revenue growth, but it operates in a sector with favorable momentum that could support its performance.
The market seems to have priced in a low expectations gap, indicating that investors are not overly optimistic about AMWL's near-term performance. Valuation is considered cheap compared to peers, but the overall confidence in the model is low.
Management has reaffirmed revenue guidance, but recent revenue has shown a declining trend. The near-term risk of missing guidance is low, yet the company has a history of erratic earnings surprises, which adds uncertainty.
The future performance of AMWL largely depends on the guidance provided in upcoming earnings calls and the performance of sector bellwethers like VEEV, BTSG, and TEM. Positive momentum in the healthcare sector could provide a lift, while negative trends from these peers could pose risks.
Overall, AMWL's outlook is cautious as it navigates management priorities and sector conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. AMWL has experienced a sharp drop in price. This drop suggests the market is repricing the reasons to own the stock. The company has not recently released earnings, which adds uncertainty to its outlook.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will provide insight into financial health and growth prospects. Investors will be looking for signs of improvement.
Confirms one read:Earnings report shows a positive surprise in revenue or earnings per share.
Confirms the other:Earnings report shows a negative surprise in revenue or earnings per share.
Why it matters: Falling below this target would show ongoing revenue problems. It would hurt growth confidence.
Confirms:Q2 2026 revenue reported at less than $48 million.
Disproves:Q2 2026 revenue reported at $48 million or higher.
Why it matters: Changes in leadership can change the company's path. This can also impact investor trust.
Confirms:There is news of a new executive hire that fits strategic goals.
Disproves:More key executives are leaving. There are no clear plans for their replacements.
Why it matters: Progress or setbacks in this partnership could impact growth. It is a key part of management's strategy.
Confirms one read:There is news about a new project or success with Elevance Health.
Confirms the other:News of challenges or delays in the partnership with Elevance Health.
Why it matters: Reaffirming this guidance would show management's confidence despite recent revenue declines. It is key for investor trust.
Confirms:Management confirms the 2026 revenue goal in the next earnings call.
Disproves:Management lowers the 2026 revenue goal to below $195M.
Why it matters: Faster revenue growth would be a good sign for American Well. It may show recovery in a growing sector.
Confirms:Q2 revenue growth exceeds 10% year over year.
Disproves:Q2 revenue growth remains below 10% year over year.
Why it matters: Positive cash flow would prove management's plan works. It would make investors feel better.
Confirms:Reported positive cash flow from operations in Q4 2026.
Disproves:Negative cash flow reported in Q4 2026.
